Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lisa G Abbott
Observed names:
LISA ABBOTT,
Lisa Abbott
Observed institution:
University of Nevada, Reno
OpenAlex ID:
A5027070243
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial
2020
·
Aliya A Khan
, Mishaela R Rubin
, et al.
·
Journal of Bone and Mineral Research
·
114
PDF
Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial
2024
·
Bart L Clarke
, Aliya A Khan
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
46
Open-label extension of a randomized trial investigating safety and efficacy of rhPTH(1–84) in hypoparathyroidism
2024
·
Aliya A Khan
, Lisa G Abbott
, et al.
·
JBMR Plus
·
4
PDF
OR23-05 Log-term Efficacy And Safety Of Transcon PTH In Adults With Hypoparathyroidism: 52-week Results From The Open-label Extension Of The Phase 3 Pathway Trial
2023
·
Bart Clarke
, Aliya Aziz Khan
, et al.
·
Journal of the Endocrine Society
·
2
PDF
OR10-05 Efficacy and Safety of Palopegteriparatide Treatment in Adults With Hypoparathyroidism: 3-Year Results From The Phase 3 PaTHway Trial
2025
·
Aliya Aziz Khan
, Bart Lyman Clarke
, et al.
·
Journal of the Endocrine Society
·
1
PDF
Efficacy and Safety of Palopegteriparatide Treatment in Adults With Hypoparathyroidism: 3-Year Results From the Phase 3 PaTHway Trial
2026
·
Neil Gittoes
, Aliya Khan
, et al.
·
Endocrine Abstracts
Efficacy and Safety of Palopegteriparatide Treatment in Adults With Hypoparathyroidism: 3-Year Results From the Phase 3 PaTHway Trial
2025
·
ALIYA A. KHAN
, BART CLARKE
, et al.
·
Canadian Journal of Diabetes
Show more works
View as search
Works count:
7
Citation count:
165
H-index:
3
I10-index:
2
Year
Topic
Type
